TY - JOUR
T1 - Probucol reduces the cellularity of aortic intimal thickening at anastomotic regions adjacent to prosthetic grafts in cholesterol-fed rabbits
AU - Baumann, Dirk S.
AU - Doblas, Manuel
AU - Schonfeld, Gustav
AU - Sicard, Gregorio A.
AU - Daugherty, Alan
PY - 1994
Y1 - 1994
N2 - Intimal hyperplasia is a persistent problem after implantation of prosthetic grafts. Although the mechanisms underlying this hyperplastic response are unknown, it has been proposed that such responses may be due to chronic vascular injury similar to that of atherogenesis. Thus, the role of oxidation was explored using the potent antioxidant drug probucol. Adult New Zealand White rabbits fed a modestly (0.25%) cholesterol-enriched diet had a polytetrafluoroethylene prosthetic graft placed into the lower aorta. After the grafting procedure, a group of 11 rabbits was placed on the cholesterol-enriched diet supplemented with 1% wt/wt probucol while a control group of 10 rabbits was placed on the cholesterol-enriched diet alone. The rabbits were maintained for a further 10 weeks before histological examination of the area surrounding the graft. Although administration of probucol did not significantly alter the dimensions of lesions at the anastomotic sites, the drug promoted striking histological changes in the surrounding tissue. Both groups of rabbits had a similar intimal hyperplastic response of the aortic tissue surrounding the graft. The vascular lesions present in the perigraft region of the control group consisted of a normal-appearing media but a thickened intima. The thickened intima contained numerous smooth muscle cells in a network of extracellular matrix. Regions in the neointima that were rich in smooth muscle cells exhibited modest staining for proliferating cell nuclear antigen. A few macrophages were present in the control group as determined by immunostaining with the monoclonal antibody RAM-11. In contrast, administration of probucol led to a marked reduction in the presence of RAM-11-staining macrophages. There was also a marked reduction in the cellularity of lesions, from 934±135 nuclei/mm2 in the control group versus 358±32 nuclei/mm2 in probucol-treated rabbits. Thus, administration of probucol did not significantly reduce the size of the intimai thickening at the relatively early interval under study, but the drug did produce cellular changes that may have beneficial effects on the main-tenance of long-term patency of implanted grafts.
AB - Intimal hyperplasia is a persistent problem after implantation of prosthetic grafts. Although the mechanisms underlying this hyperplastic response are unknown, it has been proposed that such responses may be due to chronic vascular injury similar to that of atherogenesis. Thus, the role of oxidation was explored using the potent antioxidant drug probucol. Adult New Zealand White rabbits fed a modestly (0.25%) cholesterol-enriched diet had a polytetrafluoroethylene prosthetic graft placed into the lower aorta. After the grafting procedure, a group of 11 rabbits was placed on the cholesterol-enriched diet supplemented with 1% wt/wt probucol while a control group of 10 rabbits was placed on the cholesterol-enriched diet alone. The rabbits were maintained for a further 10 weeks before histological examination of the area surrounding the graft. Although administration of probucol did not significantly alter the dimensions of lesions at the anastomotic sites, the drug promoted striking histological changes in the surrounding tissue. Both groups of rabbits had a similar intimal hyperplastic response of the aortic tissue surrounding the graft. The vascular lesions present in the perigraft region of the control group consisted of a normal-appearing media but a thickened intima. The thickened intima contained numerous smooth muscle cells in a network of extracellular matrix. Regions in the neointima that were rich in smooth muscle cells exhibited modest staining for proliferating cell nuclear antigen. A few macrophages were present in the control group as determined by immunostaining with the monoclonal antibody RAM-11. In contrast, administration of probucol led to a marked reduction in the presence of RAM-11-staining macrophages. There was also a marked reduction in the cellularity of lesions, from 934±135 nuclei/mm2 in the control group versus 358±32 nuclei/mm2 in probucol-treated rabbits. Thus, administration of probucol did not significantly reduce the size of the intimai thickening at the relatively early interval under study, but the drug did produce cellular changes that may have beneficial effects on the main-tenance of long-term patency of implanted grafts.
KW - Intimal thickening
KW - Oxidation
KW - Probucol
KW - Prosthetic grafts
UR - http://www.scopus.com/inward/record.url?scp=0028158297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028158297&partnerID=8YFLogxK
U2 - 10.1161/01.ATV.14.1.162
DO - 10.1161/01.ATV.14.1.162
M3 - Article
C2 - 8274472
AN - SCOPUS:0028158297
SN - 1079-5642
VL - 14
SP - 162
EP - 167
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
IS - 1
ER -